Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment

Drug Development and Industrial Pharmacy

Volumn 40, Issue 3, 2014, Pages 409-417

  Reis, Catarina Pinto ^a   Martinho, Nuno ^a   Rosado, Catarina ^a   Fernandes, Ana S ^a   Roberto, Amílcar ^a  

^a UNIVERSIDADE LUSÓFONA DE HUMANIDADES E TECNOLOGIAS   (Portugal)

Author keywords

Azelaic acid; Controlled release; Drug delivery systems; Freeze drying; in vitro models; M SESD method; Toxicology

Indexed keywords

AZELAIC ACID; MANNITOL; NANOPARTICLE; POLOXAMER; POLYGLACTIN;

ACNE; ARTICLE; CENTRIFUGATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; ENCAPSULATION; FREEZE DRYING; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; SACCHAROMYCES CEREVISIAE; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL;

ACNE VULGARIS; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DICARBOXYLIC ACIDS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FREEZE DRYING; LACTIC ACID; MANNITOL; NANOPARTICLES; PARTICLE SIZE; POLOXAMER; POLYGLYCOLIC ACID; POLYMERS; POROSITY; SACCHAROMYCES CEREVISIAE; TOXICITY TESTS;

EID: 84893929708     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2013.767826     Document Type: Article

References (47)

1. Rolland A, Wagner N, Chatelus A, et al. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res 1993;10:1738-44.
2. Toll R, Jacobi U, Richter H, et al. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 2004;123:168-76.
3. Vogt A, Combadiere B, Hadam S, et al. 40 nm, but not 750 or 1500 nm, nanoparticles enter epidermal CD1a cells after transcu-taneous application on human skin. J Invest Dermatol 2006; 126:1316-22.
4. Alvarez-Roman R, Naik A, Kalia YN, et al. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004; 21:1818-25.
5. Patzelt A, Richter H, Knorr F, et al. Selective follicular targeting by modification of the particle sizes. J Control Release 2011;150:45-8.
6. Litvinov D, Selvarajan K, Garelnabi M, et al. Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice. Atherosclerosis 2010;209:449-54.
7. Addo-Boadu K, Wojta J, Christ G, et al. Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro. Cancer Lett 1996;103:125-9.
8. Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med 2000;9:179-87.
9. Manosroi J, Apriyani MG, Foe K, Manosroi A. Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-beta-cyclodextrin. Int J Pharm 2005;293:235-40.
10. Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003;42:1287-304.
11. Bojar RA, Cutcliffe AG, Graupe K, et al. Follicular concentrations of azelaic acid after a single topical application. Br J Dermatol 1993;129:399-402.
12. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475-90.
13. Semete B, Booysen L, Lemmer Y, et al. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine: NBM 2010;6:662-71.
14. Jang JY, Kwon BS, Lee HE, et al. Preparation of biodegradable PLGA nanospheres employing a fast solvent evaporation method. J Ind Eng Chem 2007;13:1043-6.
15. Cheng FY, Wang SP, Su CH, et al. Stabilizer-free poly(lactide-co- glycolide) nanoparticles for multimodal biomedical probes. Biomaterials 2008;29:2104-12.
16. Contreras JEL. Human skin drug delivery using biodegradable PLGA-nanoparticles. Saarbrücken: University of Saarlandes; 2007.
17. Rancan F, Papakostas D, Hadam S, et al. Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res 2009;26:2027-36.
18. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm 1999;187:143-52.
19. Roberto A, Caetano PP. A high-throughput screening method for general cytotoxicity part I chemical toxicity. Rev Lusófona de Ciências e Tecnologias da Saúde 2005;2:95-100.
20. Quintanar-Guerrero D, Allemann E, Doelker E, Fessi H. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique. Pharm Res 1998;15:1056-62.
21. Esmaeili F, Atyabi F, Dinarvand R. Preparation and characterization of estradiol-loaded PLGA nanoparticles using homogeniza-tion-solvent diffusion method. DARU J Pharm Sci 2008;16: 196-202.
22. Esmaeili F, Atyabi F, Dinarvand R. Preparation of PLGA nanoparticles using TPGS in the spontaneous emulsification solvent diffusion method. J Exp Nanosci 2007;2:183-92.
23. Parajo Y, d'Angelo I, Horvath A, et al. PLGA: poloxamer blend micro-and nanoparticles as controlled release systems for synthetic proangiogenic factors. Eur J Pharm Sci 2010;41:644-9.
24. Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res 2004; 27:1-12.
25. Choi SH, Park TG. G-CSF loaded biodegradable PLGA nanopar-ticles prepared by a single oil-in-water emulsion method. Int J Pharm 2006;311:223-8.
26. Musumeci T, Vicari L, Ventura CA, et al. Lyoprotected nanosphere formulations for paclitaxel controlled delivery. J Nanosci Nanotechnol 2006;6:3118-25.
27. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009; 26:1025-58.
28. Geng H, Song H, Qi J, Cui D. Sustained release of VEGF from PLGA nanoparticles embedded thermo-sensitive hydrogel in full-thickness porcine bladder acellular matrix. Nanoscale Res Lett 2011;6:312-19.
29. Korting HC, Schafer-Korting M. Carriers in the topical treatment of skin disease. In: Ganten D, Page CP, Rosenthal W, et al, eds. Handbook of experimental pharmacology. Berlin: Springer; 2010:435-68.
30. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 2002;82:105-14.
31. Yang R, Shim W-S, Cui F-D, et al. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Int J Pharm 2009;371:142-7.
32. Santander-Ortega MJ, Jodar-Reyes AB, Csaba N, et al. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. J Colloid Interface Sci 2006;302:522-9.
33. Liu G, Miao X, Fan W, et al. Porous PLGA microspheres effectively loaded with BSA protein by electrospraying combined with phase separation in liquid nitrogen. J Biomim Biomater Tissue Eng 2010;6:1-18.
34. Hammady T, El-Gindy A, Lejmi E, et al. Characteristics and properties of nanospheres co-loaded with lipophilic and hydrophilic drug models. Int J Pharm 2009; 369:185-95.
35. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33.
36. Muthu M. Nanoparticles based on PLGA and its co-polymer: an overview. Asian J Pharm 2009;3:266-73.
37. Sahana DK, Mittal G, Bhardwaj V, Kumar MNVR. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci 2008;97:1530-42.
38. Fernández-Carballido A, Herrero-Vanrell R, Molina-Mart́inez IT, Pastoriza P. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration effect of labrafil addition on release in vitro. Int J Pharm 2004;279:33-41.
39. Chan JM, Zhang L, Yuet KP, et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 2009;30:1627-34.
40. Li N, Wu X, Jia W, et al. Effect of ionization and vehicle on skin absorption and penetration of azelaic acid. Drug Dev Ind Pharm 2012;38:985-94.
41. Takahashi K, Sakano H, Rytting JH, et al. Influence of pH on the permeability of p-toluidine and aminopyrine through shed snake skin as a model membrane. Drug Dev Ind Pharm 2001;27:159-64.
42. Kitamura T, Todo H, Sugibayashi K. Effect of several electrolyzed waters on the skin permeation of lidocaine, benzoic acid, and isosorbide mononitrate. Drug Dev Ind Pharm 2009;35:145-53.
43. Castro GA, Orefice RL, Vilela JM, et al. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J Microencapsul 2007;24:395-407.
44. Wang F, Chen Y, Benson HAE. Formulation of nano and micro PLGA particles of the model peptide insulin: preparation, characterization, stability and deposition in human skin. Open Drug Deliv J 2008;2:1-9.
45. 2 nanoparticles to the yeast, Saccharomyces cerevisiae. J Hazard Mater 2011;192:1572-9.
46. Nafee N, Schneider M, Schaefer UF, Lehr CM. Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotox-icity profile. Int J Pharm 2009;381:130-9.
47. Yan F, Zhang C, Zheng Y, et al. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine: NBM 2010;6:170-8.